%0 Journal Article %A Sébastien Benzekry %A Coline Sentis %A Carole Coze %A Laëtitia Tessonnier %A Nicolas André %T Descriptive and prognostic value of a computational model of metastasis in high-risk neuroblastoma %D 2020 %R 10.1101/2020.03.26.20042192 %J medRxiv %P 2020.03.26.20042192 %X High Risk Neuroblastoma (HRNB) is the second most frequent solid tumor in children. Prognosis remains poor despite multimodal therapies. Mathematical models have been developed to describe metastasis, but their prognosis value has yet to be determined and none exists in neuroblastoma.We established such a model for HRNB relying on two coefficients: α(growth) and μ (dissemination). The model was calibrated using diagnosis values of primary tumor size, lactate dehydrogenase circulating levels (LDH) and the meta-iodo-benzyl-guanidine (mIBG) SIOPEN score from nuclear imaging, using data from 49 metastatic patients treated according to the European HR_NBL1 protocol.The model was able to accurately describe the data for both total tumor mass (LDH, R2 > 0.99) and number of visible metastasis (SIOPEN, R2 = 0.96). Statistical analysis revealed significant association of LDH with overall survival (OS, p=0.0268). However, clinical variables alone were not able to generate a Cox-based model with sufficient prognosis ability (p=0.507). The parameter μ was found to be independent of the clinical variables and positively significantly associated with OS (p = 0.0175 in multivariate analysis). Critically, addition of this novel computational biomarker to the clinical data drastically improved the performances of predictive algorithms, with a concordance index in cross-validation going from 0.755 to 0.827. The resulting signature had significant prognosis ability of OS (p=0.0353).Mechanistic modeling was able to describe pathophysiological data of metastatic HRNB and outperformed the predictive value of clinical variables. The physiological substrate underlying these results has yet to be explored, and results should be confirmed in a larger cohort.Significance A mechanistic mathematical model of metastasis in high risk neuroblastoma is able to describe clinical data and provides a numerical biomarker with superior predictive power of overall survival than clinical data alone.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available upon acceptance of the manuscript for publication in a peer-reviewed journal %U https://www.medrxiv.org/content/medrxiv/early/2020/03/30/2020.03.26.20042192.full.pdf